Stockreport

Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights

Tectonic Therapeutic, Inc.  (TECX) 
PDF Positive topline data from Part B of the TX45 Phase 1b trial demonstrated improvements in both left heart function and pulmonary hemodynamics in patients with Group 2 Pu [Read more]